Latest publications for September 2021 from Cochrane Infectious Diseases Group
During September 2021, we have published two new protocols and one updated review in Issue 9, 2021 of the Cochrane Database of Systematic Reviews.
Updated review
- Shah MP, Hwang J, Choi L, Lindblade KA, Kachur SP, Desai M. Mass drug administration for malaria. Cochrane Database of Systematic Reviews 2021, Issue 9. Art. No.: CD008846. DOI: 10.1002/14651858.CD008846.pub3
Read the LSTM news story here: www.lstmed.ac.uk/news-events/news/treating-everyone-for-malaria-does-it-eliminate-the-disease
Protocols
- Engel N, Ochodo EA, Karanja PW, Schmidt B-M, Janssen R, Steingart KR, Oliver S. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views. Cochrane Database of Systematic Reviews 2021, Issue 9. Art. No.: CD014877. DOI: 10.1002/14651858.CD014877
- Verbakel JY, De Rop L, Stegeman I, Holtman GA, Ochodo EA, Yang B, Guleid F, Davenport C, Deeks JJ, Dinnes J, Dittrich S, Emperador D, Hooft L, Spijker R, Van den Bruel A, Wang J, Takwoingi Y, Langendam MW, Leeflang MMG. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID‐19 in people with SARS‐CoV‐2. Cochrane Database of Systematic Reviews 2021, Issue 9. Art. No.: CD015050. DOI: 10.1002/14651858.CD015050
Throughout 2021, we will continue to add publications to our CIDG and READ-It websites regularly. Do continue to check our websites for updates and follow us on Twitter:
https://twitter.com/Cochrane_IDG
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.